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Summary
Background Epidermolytic hyperkeratosis in humans is caused by dominant-negat-
ive mutations in suprabasal epidermal keratins 1 and 10. However, spontaneous
keratin mutations have not been confirmed in a species other than human.
Objectives To describe an autosomal recessive, mild, nonpalmar ⁄plantar epidermo-
lytic ichthyosis segregating in an extended pedigree of Norfolk terrier dogs due
to a splice-site mutation in the gene encoding keratin 10 (KRT10).
Methods Dogs were evaluated clinically, and skin samples were examined by light
and electron microscopy. Genomic DNA samples and cDNA from skin RNA were
sequenced and defined a mutation in KRT10. Consequences of the mutation were
evaluated by assessing protein expression with immunohistochemistry and West-
ern blotting and gene expression with real-time RT-PCR (reverse transcriptase-
polymerase chain reaction).
Results Adult dogs with the disease had generalized, pigmented hyperkeratosis
with epidermal fragility. Light microscopic examination defined epidermolysis
with hyperkeratosis; ultrastructural changes included a decrease in tonofilaments
and abnormal filament aggregation in upper spinous and granular layer keratino-
cytes. Affected dogs were homozygous for a single base GT fi TT change in the
consensus donor splice site of intron 5 in KRT10. Keratin 10 protein was not
detected with immunoblotting in affected dogs. Heterozygous dogs were normal
based on clinical and histological appearance and keratin 10 protein expression.
The mutation caused activation of at least three cryptic or alternative splice sites.
Use of the cryptic sites resulted in transcripts containing premature termination
codons. One transcript could result in shortening of the proximal portion of the
2B domain before the stutter region. Quantitative real-time PCR indicated a signi-
ficant decrease in KRT10 mRNA levels in affected dogs compared with wild-type
dogs.
Conclusions This disease is the first confirmed spontaneous keratin mutation in a
nonhuman species and is the first reported recessive form of epidermolytic
hyperkeratosis.
Keratin intermediate filaments are essential for structural stabil-
ity of epidermal keratinocytes and normal stratum corneum
formation. Thus, mutations of epidermal keratin genes are
largely characterized by haphazard filament aggregation and
cell fragility, often resulting in cell lysis (epidermolysis) that
is more severe with exposure to trauma.1–4 In most mutations
of the superficial keratins (KRT1, 10, 2e) blisters and hyper-
keratosis are both present. Blistering is most apparent in chil-
dren, where the disease is often called bullous congenital
ichthyosiform erythroderma, while scaling is more prominent
in adults, where the same disease can also be called epidermo-
lytic hyperkeratosis (EHK).5
Many different allelic variations occur in genetic disorders
of superficial keratins. A recent review listed 22 mutations in
KRT1 and 38 in KRT10.6 A majority of these mutations are
missense mutations and occur in two ‘hot spot’ regions of the
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molecule: the helix initiation and helix termination motifs.
Most keratin mutations are transmitted by an autosomal dom-
inant mode of inheritance.6
With the number of keratin mutations that have been iden-
tified in humans, and their distinctive clinical and histological
features, it is surprising that no spontaneous keratin defect has
been confirmed in a species other than human. To date, the
recognition of animals with a phenotype of a spontaneous
keratinization defect has occurred only in dogs. A Labrador
Retriever,7 a mixed breed dog,8 and arguably, Cavalier King
Charles spaniels9 have been noted with hyperkeratosis, epi-
dermolysis and ⁄or perinuclear aggregation of tonofilaments
and cytoplasmic vacuolation, but none of these cases was con-
firmed at the molecular level.
In this report, we confirm the first spontaneous heritable
keratin defect described in a species other than human. The
disease represents a novel mutation in KRT10 transmitted as a
recessive trait through an extended pedigree of Norfolk terrier
dogs.10 Affected dogs display lesions from birth through
adulthood with all of the hallmarks of a mild, superficial, non-
palmar ⁄plantar epidermolytic ichthyosis while heterozygotes
are clinically and histologically normal.
Materials and methods
All procedures relating to animal care in this study were
approved by the Clinical Research Review Committee, College
of Veterinary Medicine, Texas A & M University, approval
number CRRC 02-25.
Animals
The clinical disease was recognized in seven affected (four
female and three male) Norfolk terrier dogs within an
extended pedigree and these dogs were compared with nor-
mal dogs of the same breed. Normal, heterozygous and
affected dogs were available for sampling throughout the
course of the study.
Tissue sampling
A 6-mm punch biopsy and local anaesthesia were used to
obtain skin samples for histological and ultrastructural exami-
nation, RNA isolation and protein extraction. Both peripheral
blood and cheek swabs were used as sources of genomic
DNA.
Light and electron microscopy
For histology, skin biopsy samples were fixed with 10% neut-
ral buffered formalin, processed routinely, embedded in paraf-
fin, sectioned at 4–5 lm and stained with haematoxylin and
eosin. Immunohistochemistry was performed on formalin-
fixed skin samples using commercially available antibodies that
previously had been shown to display the appropriate cross-
reactivity with canine antigens: 34bB4 (Enzo, Farmingdale,
NY, U.S.A.) demonstrated K1 expression, and DE-K10 (Dako,
Carpinteria, CA, U.S.A.) demonstrated K10 expression.7,11 For
electron microscopy, formalin-fixed tissues were postfixed
with 1% osmium tetroxide in 0Æ1 mol L)1 phosphate buffer
and processed routinely. Sections were stained with aqueous
uranyl acetate and lead citrate and examined with a Phillips
301 Transmission Electron Microscope.10
Sequencing
Genomic DNA was extracted from blood leucocytes with the
Flexigene DNA kit (Qiagen, Valencia, CA, U.S.A.) as per the
manufacturer’s protocol. To obtain skin cDNA, punch biopsy
samples stored at ) 80 C and ⁄or in RNALater (Ambion, Aus-
tin, TX, U.S.A.) were subjected to total RNA extraction using
Trizol Reagent (Gibco BRL, Rockville, MD, U.S.A.) as per the
manufacturer’s protocol and subsequently, reverse transcription
of total RNA was performed using random primers provided
in the Pro-Star reverse transcriptase-polymerase chain reaction
(RT-PCR) kit (Stratagene, La Jolla, CA, U.S.A.). Primers
designed to amplify canine KRT10 sequences from skin cDNA
or genomic DNA templates were initially derived from con-
served nucleotide regions of human (NM_000421 and
X_14487) and mouse (XM_283025) K10. As data were collect-
ed, canine-specific primers were designed. For amplification,
the Failsafe PCR system (Epicentre, Madison, WI, U.S.A.) was
employed according to the manufacturer’s protocol. The PCR
products were resolved by electrophoresis through agarose
gels ranging from 1Æ4% to 2Æ0%. PCR products with bands of
appropriate length, as predicted from human KRT10, were
purified directly or by gel extraction (Qiagen). Products were
sequenced directly using a Perkin Elmer ABI 373, 377XL or
3100 system. Sequence data were aligned using Sequencher
3.1.1 (Gene Codes Corporation, Ann Arbor, MI, U.S.A.). The
putative amino acid sequence was determined using the trans-
lation software on the ExPASy Molecular Biology Server
(http://us.expasy.org; accessed 13 March 2005).
Mutation detection assay
Genomic DNA was extracted from buccal epithelial cells with
the QIAamp Midi kit (Qiagen). A 660-bp region of genomic
DNA spanning the mutation was amplified using the Failsafe
PCR system (Epicentre) with buffer J, 1Æ0 lL of 0Æ2 mmol L)1
forward primer (5¢-CCTTCCAGGGATTGTTTCTGC-3¢), 1Æ0 lL
of 0Æ2 mmol L)1 reverse primer (5¢-AAGGAACTGACTACAGA-
AATCAACAG-3¢), and 2Æ0 lL of DNA. A restriction digest was
performed using 15 lL of PCR product, 30 lL of water,
5Æ0 lL of buffer R+ and 1Æ0 unit of MvaI (Fermentas, Hanover,
MD, U.S.A.) at 37 C for 1 h; 8Æ0 lL of digestion product was
electrophoresed on a 2% agarose gel.
Immunoblotting
Keratinocytes were harvested from punch biopsy samples by
solubilization in Laemmli-type sample buffer and protein was
 2005 British Association of Dermatologists • British Journal of Dermatology 2005 153, pp51–58
52 Canine recessive keratin 10 mutation, K.M. Credille et al.
quantified using the BCA assay (Pierce, Rockford, IL, U.S.A.).
b-Mercaptoethanol (4%) was added to extracts after quantifi-
cation. Protein (12 lg per sample) was electrophoresed on a
10% Tris–HCl ⁄glycine ⁄sodium dodecyl sulphate–polyacryla-
mide gel and proteins were transferred by overnight electro-
blotting to nitrocellulose membranes. The membranes were
incubated with a 1 : 50 dilution of primary antibody (K10,
clone RKS60) (Chemicon, Temecula, CA, U.S.A.). After
washing in phosphate-buffered saline, the membrane was
incubated with a 1 : 2500 dilution of goat antimouse IgG
conjugated with alkaline phosphatase (Sigma, St Louis, MO,
U.S.A.). After washing, the phosphatase activity was detected
with the chromogenic substrate BCIP ⁄NBT (Sigma).
TaqMan quantitative real-time polymerase chain
reaction analysis
Total RNA was extracted from 6-mm skin punch biopsy samples
from four homozygous normal dogs, four carrier (heterozy-
gous) dogs and four affected dogs with the RNAqueous-micro
kit (Ambion). The RNA was subsequently treated with DNase-
free (Ambion) to remove genomic DNA contamination, quan-
tified with RiboGreen (Molecular Probes, Eugene, OR, U.S.A.)
and stored at ) 80 C. Quantitative real-time RT-PCR was per-
formed with 10 ng of total RNA ⁄reaction and the TaqMan
One-step RT-PCR Master Mix reagents kit (Applied Biosystems,
Foster City, CA, U.S.A.). Gene-specific primers for KRT10
(forward primer 5¢-CCTGCTTCAGATCGACAATGC-3¢; reverse
primer 5¢-ACCTCGTTCTCATACTTTAATCTGAAGTC-3¢) and a
TaqMan probe (5¢-AGGCTGGCAGCTGA-3¢) containing an
MGBNFQ (Minor groove binder ⁄nonfluorescent quencher) 3¢
label and a 6FAMTM 5¢ label (Applied Biosystems) were
designed using Perkin-Elmer Applied Biosystems Primer
Express software. Primers were designed to cross at least one
intron–exon boundary. The highly conserved regions of the
keratin genes, particularly the trigger motifs and the H1
homologous region, were strictly avoided when designing
primers to help ensure a high level of specificity. The forward
primer was designed to bind to the middle of exon 2. The
reverse primer was located at the end of exon 2 and crossed
the intron to include the beginning of exon 3. The product
size was 66 bp. The probe was designed to bind in the region
between the primers. A GeneAmp 5700 Sequence Detection
System (Applied Biosystems) was used for quantification. The
amplification program consisted of an initial 95 C, 10-min
cycle followed by 40 cycles of 95 C 15-s denaturation and
60 C 1-min annealing ⁄extension. Samples were analysed in
triplicate for the expression of KRT10 and an internal house-
keeping gene, 18S ribosomal RNA (Applied Biosystems).
The threshold cycle values for each replicate reaction were
averaged. All genes were normalized to 18S ribosomal RNA,
and the fold change was calculated with the formula: X ¼
2–DDCt where DDCt ¼ (Ct,target ) Ct,reference)sample ) (Ct,target )
Ct,reference)normal. Target refers to the gene of interest, and ref-
erence refers to the internal control gene. ‘Sample’ refers to
affected skin, and ‘normal’ refers to normal skin.12
Statistical analysis
Triplicate measurements of mRNA expression for KRT10 and
18S using real-time PCR were obtained from each normal
(n ¼ 4), carrier (n ¼ 4) and affected (n ¼ 4) skin biopsy
sample. Due to the possibility of interassay variability, a sec-
ond run was performed on each sample for a total of six
measurements. The arithmetic mean of these measurements
was obtained and relative differences between KRT10 and 18S
calculated. A nonparametric version of the unpaired t-test
(Mann–Whitney) was used to compare the relative differences
between homozygous normal, heterozygous and affected skin
with statistical significance taken at P < 0Æ05.
Results
Clinical description
An eight-generation pedigree containing 108 dogs was assem-
bled and was consistent with an autosomal recessive mode of
inheritance (Fig. 1). The pedigree contained seven affected
dogs and 33 obligate and ⁄or genetically confirmed heterozy-
gotes. Clinically, affected dogs were identified within hours
after birth by sloughing of the superficial epidermis after mild
mechanical trauma to the skin. As adults, the epidermal fragil-
ity persisted and was accompanied by hyperpigmentation with
generalized dark grey hyperkeratosis; the intertriginous areas
were most severely affected (Fig. 2). Erythroderma was not
noted. Several affected dogs over 10 years of age were
observed and their clinical lesions remained static once they
reached adulthood. Footpads, claws, hair and teeth were nor-
mal. Heterozygous dogs were clinically normal at all ages.
Light and electron microscopy
In affected dogs, the most striking histological alteration was
the presence of granular cell layer epidermolysis that pro-
gressed to areas of intragranular clefting. This was associated
with large keratohyaline granules, a minimally to moderately
thickened stratum corneum with attenuated corneocytes and
mild to moderately papillated epidermal hyperplasia (Fig. 3).
None of these changes was present in heterozygotes. Immu-
nohistochemical staining for K10 using formalin-fixed, paraf-
fin-embedded skin biopsy samples failed to define K10
expression in the epidermis of affected dogs, while there was
strong, positive staining of the suprabasal epidermis of normal
Norfolk terrier dogs, Norfolk terrier dogs heterozygous for the
mutation and other normal canine breeds.10 Electron micro-
scopy confirmed cytolysis, decreased tonofilaments and abnor-
mal tonofilament clumping in affected dogs.
Mutation detection
A complete genomic sequence of canine KRT10 (GenBank
accession AY318944) was determined using oligonucleotide
primers for PCR designed initially from homologous regions
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of previously reported human and mouse DNA sequences and
later from canine sequences. DNA sequencing of a PCR prod-
uct resulting from amplification of genomic DNA from affect-
ed dogs using a canine-specific forward primer in exon 4
(5¢-TCTAGCAGGCTGCGGTAGG-3¢) paired with a reverse
primer in exon 6 (5¢-GATGCTGAAGCCTGGTTCAATG-3¢)
revealed a single base GT fi TT change in the consensus
donor splice site of intron 5. Sequencing of the same amplifi-
cation product in DNA samples from parents of affected dogs
(obligate heterozygotes) showed that both the wild-type allele
and TT mutant allele were present. The expected GT consensus
sequence was present in multiple normal Norfolk terrier dogs
not from lines related to affected dogs and in multiple other
breeds (Fig. 4). No additional nucleotide differences between
normal and affected dogs were identified.
a
b
Fig 2. Clinical features of the disease. (a) Moderate black scale is
present in the haircoat. (b) The skin is hyperkeratotic and
hyperpigmented. Mild mechanical trauma results in superficial bulla




Fig 1. An eight-generation pedigree segregating epidermolytic hyperkeratosis in Norfolk terrier dogs displaying an autosomal recessive mode of
inheritance. Note: The symbols + and * indicate the same dog.
Fig 3. Histological examination of a skin biopsy sample from an
affected dog. Characteristic features include epidermal hyperplasia
with superficial epidermolysis, large keratohyaline granules, many
eosinophilic intracytoplasmic granules, and a hyperkeratotic stratum
corneum. Keratohyaline granules are variably present in normal canine
epidermis. In contrast to the large keratohyaline granules found in
affected dogs, the arrows indicate keratohyaline granules that are more
typical in size when these structures are identified. Haematoxylin and
eosin, original magnification · 400.
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To examine the effects of the splice-site mutation, the pre-
viously described primer set spanning this site was used to
amplify canine KRT10 cDNA from affected and homozygous
wild-type Norfolk terrier dogs. Agarose gel electrophoresis
revealed an expected single 359-bp band in normal dogs. In
affected dogs, the 359-bp band was not detected and multiple
smaller and larger bands were identified (Fig. 5). Three of
these aberrant amplification products were isolated, re-ampli-
fied and sequenced directly. The smallest band (approximately
230 bp) represented the in-frame and entire removal of exon
5 (126 nucleotides) and could be explained by the alternative
use of the normal intron 4 GT site. If translated, this mis-
spliced transcript would produce a deletion of 42 amino acids
from the proximal portion of the 2B rod domain before the
stutter. The brightest amplification product (approximately
330 bp) corresponded to a 35-bp out-of-frame deletion of the
end of exon 5. This probably occurred due to activation of a
cryptic splice site within exon 5 (GTCTG). The sequence of
this product was out of frame and contained an insertion of
114 incorrect nucleotides followed by a premature termin-
ation codon. If translated, the misspliced transcript would
encode for 38 incorrect amino acids in the mid 2B domain
and then termination of the molecule. Sequencing of a third
larger band (approximately 450 bp) showed it contained a
95-bp out-of-frame inclusion at the 5¢ end of intron 5 that
was probably due to the use of a GT sequence within intron 5
(GTAAG). This creates a premature termination codon after
the insertion of six incorrect nucleotides at the end of exon 5,
truncating the molecule in the mid 2B region.
If translated, the abnormal transcripts from these three cryp-
tic ⁄alternative splice sites would result in either a keratin
Fig 4. A novel point mutation in the donor splice site of intron 5
(GT fi TT) causes epidermolytic hyperkeratosis in dogs homozygous
for the mutation. Sequencing of KRT10 genomic DNA from normal,
affected homozygous and unaffected heterozygous dogs.
Fig 5. Polymerase chain reaction amplification of KRT10 cDNA in two affected dogs compared with a normal breed-matched dog and
corresponding line diagram illustrating the consequences of aberrant splicing of KRT10. Lane 1, 100-bp marker; lane 2, normal dog, expected
359-bp product; lanes 3 and 4, affected dogs, three aberrant bands (*) were isolated and sequenced. (*a) The normal donor site in intron 4 is
used and as a result exon 5 is removed from the transcript. The nucleotide sequence remains in frame and results in a 42 amino acid deletion
from the 2B domain. (*b) A cryptic splice site occurs upstream in exon 5, resulting in deletion of the last 35 bp of that exon. The resulting
sequence is out of frame and 38 incorrect amino acids are encoded before a premature termination codon truncates the molecule in the 2B
domain. (*c) An alternative splice site occurs downstream in intron 5, resulting in an additional 95 bp of the intron within the transcript. The
sequence is out of frame and generates a termination codon immediately following exon 5, truncating K10 in the 2B domain.
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molecule with a loss of a portion of the 2B domain or an
incomplete protein that terminates within the mid 2B rod
domain (Fig. 5). Other PCR amplification products in Figure 5
in the affected dogs were not examined and may represent
other misspliced transcripts or products generated from small
amounts of genomic DNA contaminating the cDNA samples.
Screening for the mutation
The mutation in the intron 5 donor splice site of KRT10 abol-
ishes an MvaI restriction site. Enzyme digestion of a 660-bp
PCR product spanning the mutation produces fragments of
247 bp, 208 bp and 121 bp (and three very small fragments)
from the normal allele and fragments of 329 bp and 247 bp
in the mutant allele (data not shown). MvaI digests of PCR-
amplified genomic DNA from the seven affected dogs con-
firmed that they were homozygous for this mutation. Seven of
the obligate heterozygote parents of the affected dogs were
available for testing and all were confirmed as heterozygotes.
Also, 50 clinically unaffected Norfolk terrier dogs not from
the breeding lines in which the disease is segregating and five
dogs from other breeds did not possess the nucleotide alter-
ation, indicating it is probably not a polymorphic site in dogs.
Using buccal swabs as a source of genomic DNA, this screen-
ing test has been made available to breeders of Norfolk terrier
dogs.
Keratin 10 protein expression
From previous work11 and based on the predicted amino acid
sequence, the molecular weight of canine K10 is 56–58 kDa.
A band of the predicted size was identified in protein extracts
from the skin of homozygous normal Norfolk terriers, in the
skin of a confirmed heterozygote and in the normal skin of
other breeds (data not shown), but was not found in extracts
of the skin of homozygous affected dogs (Fig. 6).
Comparison of KRT10 gene expression
Quantitative real-time PCR demonstrated a statistically signifi-
cant decrease (P < 0Æ05, Mann–Whitney) in relative mRNA
expression of KRT10 for both affected and carrier dogs com-
pared with homozygous normal dogs (Fig. 7).
Discussion
In all affected dogs, the phenotype correlated with a homozy-
gous mutation in the GT consensus sequence of the donor
splice site in intron 5 of KRT10. This represents the first time
a spontaneous keratin mutation has been confirmed in a dog
or any mammalian species other than human. Because of the
mild phenotype and the prominence of intragranular clefting,
we initially considered the disease to have greater phenotypic
homology with human ichthyosis bullosa of Siemens;4 how-
ever, we could not confirm a KRT2e mutation after comparing
the canine DNA sequences of normal and affected dogs (data
not shown).
The mutation corresponds to the proximal portion of the
2B region of the keratin molecule. In humans, a low number
of mild EHK phenotypes have been associated with mutations
in the 2B domain of KRT1 and KRT10. Mild EHK (KRT10),
mild epidermolytic palmar ⁄plantar keratoderma (PPK) (KRT1)
and mild combined EHK ⁄PPK (KRT1) have occurred due to
mutations in the 2B domain upstream from the conserved
helix termination motif sequence.13–15
As with other structural proteins that form multimers,
mutations affecting keratins usually cause a dominant negative
effect and recessive forms of these diseases are less commonly
recognized.6 The majority of recessive keratin disorders cited
are forms of epidermolysis bullosa simplex due to mutations
in KRT14,6,16,17 with a single report in KRT5.18 Most of these
mutations are nonsense mutations or missense mutations that
result in premature termination codons early in the keratin
molecule. To our knowledge, the disease in Norfolk terriers is
the first confirmed recessive mutation of a suprabasal keratin.
Because of shorter generational times, the importance
placed on pedigrees by pure-bred dog breeders, and the obvi-
ous clinical features of affected dogs, we were able to confirm
the phenotype in an eight-generation pedigree that contained
Fig 6. Immunoblot for K10 in dogs. Lane 1, extract of skin from a
homozygous normal Norfolk terrier; lane 2, extract of skin from a
homozygous affected Norfolk terrier; lane 3, extract of skin from a
heterozygous Norfolk terrier.
Fig 7. TaqMan quantitative real-time polymerase chain reaction
analysis of KRT10 mRNA comparing four homozygous normal dogs,
four heterozygotes and four affected dogs. A significant decrease in
KRT10 mRNA was found in the skin of the heterozygous and, to a
greater extent, affected dogs.
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seven affected dogs. The pedigree defined an autosomal reces-
sive mode of inheritance. We verified the genotypes of most
of the 33 heterozygotes with a mutation detection assay. All
heterozygotes were clinically normal. Of the recognized her-
editary disorders of the pure-bred dog, approximately 66%
are recessive,19 higher than in humans, where approximately
26% of monogenic diseases are recessive.20 This is due to the
emphasis on maintaining desirable traits by selective breeding
of closely related dogs (inbreeding) and the use of a sire or
dam repeatedly when it is viewed as being particularly out-
standing. At the same time, an obviously diseased animal
would not be bred; therefore, dominant traits are not main-
tained for long. In sum, the breeding practices associated with
pure-bred dogs select for recessive traits but against dominant
traits. The recognition of a recessive mutation in a suprabasal
keratin, albeit in dogs, indicates that similar recessive muta-
tions may be present in humans but are not recognized due to
the rarity of consanguinity in human pedigrees.
The Norfolk terrier KRT10 mutation is associated with the
use of multiple exonic and intronic cryptic donor sites and the
normal intron 4 donor splice-site sequence as alternative splice
sites. In affected dogs, we speculate that lesions result from
the combination of markedly decreased filament synthesis,
supported by the electron microscopy and immunoblot
results, and the production of a small amount of mutated K10
derived from misspliced in-frame transcripts, supported by the
presence of abnormal filament aggregates ultrastructurally.
Although we could amplify portions of KRT10-derived cDNA
from the skin of affected dogs by PCR, the KRT10 mRNA lev-
els were markedly lower than in breed-matched dogs homo-
zygous for the wild-type allele, suggesting that the presence
of premature termination codons or other nucleotide altera-
tions leads to nonsense-mediated decay of KRT10 transcripts.
If abnormal K10 synthesis does occur, our data indicate at
least one mutated form would be altered in the central area of
the 2B region, not within the helix termination motif.
In this study, examination of confirmed heterozygotes
shows that these dogs were normal clinically, histologically
and in terms of K10 protein expression; therefore, it appears
that haploinsufficiency did not affect keratin intermediate fil-
ament assembly. Additionally, if abnormal K10 protein was
produced, it did not disrupt the cytoskeleton sufficiently to
produce epidermolysis.
To date, the example most analogous to the Norfolk terrier
disease is a genetically modified mouse model with a K10 null
mutation. These mice have a milder phenotype than the dogs
we describe.21,22 The K10– ⁄– mice were phenotypically nor-
mal at birth and, even as adults, did not display epidermolysis,
although they did develop epidermal hyperplasia and mild
orthokeratosis, presumably related to the effect of the loss of
K10 on cell cycle control.22
A second K10 mutant mouse model demonstrates a mild
phenotype in the heterozygous state.23 This mild phenotype is
related to reduced expression of the mutant allele so the wild-
type allele can partially compensate for the mutant allele. In
the clinically and histologically normal heterozygous dogs we
did not define downregulation of the mutant allele, although
this may be confirmed in future studies. The murine and can-
ine models differ also in the homozygous state. When homo-
zygous for the ‘hot spot’ R fi C mutation in exon 1, the
mice have severe epidermolysis resulting in extensive blister-
ing and scaling.23
Finally, this represents the first report of a keratin mutation
in the intron 5 donor splice site. Splice-site mutations have
been reported rarely as causes of EHK and epidermolytic PPK,
due to mutations in KRT1, and as causes of epidermolysis bul-
losa simplex, due to mutations in both KRT5 and 14. The
splice-site mutation most similar to this case occurred in the
donor site of intron 6 in KRT1 and led to a mild epidermolytic
PPK with rare hyperkeratotic lesions in other sites.14
As this mutation is outside of the ‘hot spot’ regions for
KRT10, and is recessive, it represents a unique model to fur-
ther define genotype–phenotype correlations of suprabasal
keratin mutations.
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